Visiongain Publishes Cold Compression Therapy Market Report 2020-2030

03 August 2020
Pharma

Visiongain has launched a new pharma report Cold Compression Therapy Market Report 2020-2030: Prospects by Product (OTC products (Sprays, Gels, Roll-ons, Ointments, Creams, Patches, Cold Packs), Prescription Products (Motorized & Non-motorized Devices)), Application (Orthopedic Conditions, Post-operative Therapy, Sports Medicine, Post-trauma Therapy, Distribution channel (Hospital Pharmacy, Retail Pharmacy, eCommerce), and Geography.

Cold compression therapy involves 2 of the principles of R.I.C.E (rest, ice, compression, elevation) to reduce pain & swelling caused to soft tissues by sports/activity injuries. Specifically, this therapy is used to treat sprains, strains pulled muscles & ligaments. Cold compression is a combination of static compression and cryotherapy, typically used after surgical procedures or acute trauma to relieve inflammation & pain.

The global cold compression therapy market is anticipated to grow on account of growing advancements in technology for cold compression therapy, growing instances of arthritis, sports injuries, road accidents and growing ageing population across the globe.

The largest cause of joint diseases is the increasing elderly population. Due to cartilage degeneration and the role of excessive levels of reactive oxygen species, joint diseases are most prevalent among the elderly population. The overall ageing process creates changes in the joint tissues thus leading to osteoarthritis. Osteoarthritis (OA) is an age-related disease that causes the articular cartilage to be degraded & lost. Obesity, joint injury, genetics, & anatomical abnormalities are the major factors responsible for osteoarthritis.

There is a loss in the human body's ability to maintain homeostasis under stressful conditions among the aged population. Therefore, excessive mechanical stress leads to disease development. In contrast, osteoarthritis is mostly seen in the elderly population coupled with a joint injury. According to the CDC, the number of US adults aged 65+ is projected to surpass 95 million. For treating diseases such as arthritis, cold compression therapies are very successful. Thus, growing geriatric population & increased vulnerability to joint diseases are anticipated to boost market growth further.

North America is the largest market capturing the majority of market share owing to factors such as growing healthcare expenditure and growing geriatric population in the United States. However, Asia Pacific cold compression region is anticipated to grow with the highest CAGR over the forecast period owing to the growing patient pool in emerging economies of Japan, China & India. Also, Japan is anticipated to offer lucrative revenue generation avenues for the market players as its population is rapidly aging and its elderly population make up a third of Japan’s population.

Some of the major players operating in this industry are 3M, Beiersdorf, Bio Compression Systems, Breg, Coolsystems (Game Ready), Custom Ice, DJO Global, Hisamitsu Pharmaceutical, Hisamitsu Pharmaceutical, Medline Industries, Inc., Össur, Performance Health, Pfizer, Polar Products, PowerPlay, ROHTO Pharmaceutical Co., Ltd., Romsons Group of Industries, Sanofi, ThermoTek, Unexo Life Sciences Pvt. Ltd. among other prominent players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever